Article info
Basic and translational research
Extended report
Treatment with abatacept prevents experimental dermal fibrosis and induces regression of established inflammation-driven fibrosis
- Correspondence to Jérôme Avouac, Service de Rhumatologie A, Hôpital Cochin, Université Paris Descartes, 27 rue du Faubourg Saint-Jacques, Paris 75014, France; jerome.avouac{at}cch.aphp.fr
Citation
Treatment with abatacept prevents experimental dermal fibrosis and induces regression of established inflammation-driven fibrosis
Publication history
- Received July 10, 2015
- Revised December 15, 2015
- Accepted January 31, 2016
- First published February 24, 2016.
Online issue publication
November 10, 2016
Article Versions
- Previous version (2 May 2016).
- You are viewing the most recent version of this article.
- latest version (25 October 2017).
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/